Supriya Lifescience Limited (NSE:SUPRIYA)
898.90
-18.35 (-2.00%)
Jun 3, 2026, 1:30 PM IST
Supriya Lifescience Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 788.67 | 760.57 | 683.49 | 852.51 | 1,658 |
Short-Term Investments | - | 30.97 | 66.07 | 723.31 | 591.55 |
Cash & Short-Term Investments | 788.67 | 791.54 | 749.56 | 1,576 | 2,249 |
Cash Growth | -0.36% | 5.60% | -52.43% | -29.94% | 160.26% |
Accounts Receivable | 2,194 | 1,344 | 1,117 | 846.64 | 1,152 |
Other Receivables | - | 7.1 | 45.09 | 64.06 | 60.32 |
Receivables | 2,200 | 1,358 | 1,169 | 916.16 | 1,218 |
Inventory | 1,596 | 1,183 | 852.49 | 1,158 | 923.12 |
Prepaid Expenses | - | 102.43 | 112.25 | 108.48 | 72.45 |
Other Current Assets | 738.22 | 935.04 | 1,097 | 890.71 | 512.77 |
Total Current Assets | 5,323 | 4,370 | 3,980 | 4,649 | 4,975 |
Property, Plant & Equipment | 7,234 | 5,995 | 4,573 | 3,281 | 2,317 |
Long-Term Investments | 985.23 | 632.41 | 637.95 | 252.96 | 0.53 |
Other Intangible Assets | 13.12 | 13.89 | 16.56 | 11.06 | 15.09 |
Other Long-Term Assets | 15.81 | 111.55 | 6.8 | 9.28 | 39.82 |
Total Assets | 13,571 | 11,123 | 9,214 | 8,203 | 7,348 |
Accounts Payable | 1,108 | 745.46 | 595.69 | 642.28 | 489.72 |
Accrued Expenses | - | 30.27 | 29.61 | 27.58 | 29.58 |
Short-Term Debt | - | - | - | 166.25 | 212.95 |
Current Portion of Leases | 2.46 | 3.23 | 4.68 | 3.54 | 8.25 |
Current Income Taxes Payable | - | -50.33 | -24.68 | 45.87 | 64.11 |
Other Current Liabilities | 99.51 | 92.99 | 165.76 | 72.28 | 192.38 |
Total Current Liabilities | 1,210 | 821.62 | 771.06 | 957.8 | 996.99 |
Long-Term Leases | 51.89 | 50.57 | 50.2 | 54.89 | 52.95 |
Pension & Post-Retirement Benefits | - | - | - | 47.3 | 26.73 |
Long-Term Deferred Tax Liabilities | 312.44 | 270.18 | 231.52 | 136.75 | 111.49 |
Other Long-Term Liabilities | 18.97 | 13.17 | 8.03 | 11.45 | 2.59 |
Total Liabilities | 1,594 | 1,156 | 1,061 | 1,208 | 1,191 |
Common Stock | 160.97 | 160.97 | 160.97 | 160.97 | 160.97 |
Additional Paid-In Capital | - | 1,985 | 1,985 | 1,985 | 1,985 |
Retained Earnings | - | 7,820 | 6,004 | 4,862 | 4,011 |
Comprehensive Income & Other | 11,816 | 1.57 | 2.82 | -13.42 | -0.01 |
Shareholders' Equity | 11,977 | 9,968 | 8,154 | 6,995 | 6,157 |
Total Liabilities & Equity | 13,571 | 11,123 | 9,214 | 8,203 | 7,348 |
Total Debt | 54.35 | 53.8 | 54.88 | 224.68 | 274.15 |
Net Cash (Debt) | 734.32 | 737.74 | 694.68 | 1,351 | 1,975 |
Net Cash Growth | -0.46% | 6.20% | -48.59% | -31.59% | 1287.90% |
Net Cash Per Share | 9.12 | 9.17 | 8.63 | 16.79 | 24.54 |
Filing Date Shares Outstanding | 80.51 | 80.48 | 80.48 | 80.48 | 80.48 |
Total Common Shares Outstanding | 80.51 | 80.48 | 80.48 | 80.48 | 80.48 |
Working Capital | 4,113 | 3,549 | 3,209 | 3,691 | 3,978 |
Book Value Per Share | 148.77 | 123.85 | 101.31 | 86.91 | 76.50 |
Tangible Book Value | 11,964 | 9,954 | 8,137 | 6,984 | 6,142 |
Tangible Book Value Per Share | 148.61 | 123.67 | 101.10 | 86.77 | 76.31 |
Land | - | 109.23 | 104.16 | 91.64 | 91.6 |
Buildings | - | 1,291 | 857.69 | 724.16 | 546.76 |
Machinery | - | 3,810 | 2,621 | 2,132 | 1,474 |
Construction In Progress | - | 1,480 | 1,488 | 676.28 | 434.09 |